Details of Drug

Drug General Information (ID: D0686)
Drug Name	Fluvastatin
Drug Type	Small molecule
Drug Synonymous	Canef; Cranoc; Fluindostatin; Fluvas; Fluvastatina; Fluvastatine; Fluvastatinum; Lescol; Lescol XL; XU 62320; Canef(TN); Fluvas (TN); Fluvastatin & Primycin; Fluvastatin (INN); Fluvastatin [INN:BAN]; Fluvastatina [INN-Spanish]; Fluvastatine [INN-French]; Fluvastatinum [INN-Latin]; Lescol (TN); Vastin (TN); XU-62320; (+)-(3R,5S)-fluvastatin; (-)-(3S,5R)-fluvastatin; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; (Z,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid; 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoate; 7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid Click to Show/Hide
Disease Class	5C80: Hyper-lipoproteinaemia
Therapeutic Class	Statins/Antihyperlipidemic Agents
Structure
Structure	3D Structure		2D Structure
Formula	C24H26FNO4
InChI	1S/C24H26FNO4/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30)/b12-11+/t18-,19-/m1/s1
InChIKey	FJLGEFLZQAZZCD-MCBHFWOFSA-N
Canonical SMILES	CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
External Link
	Pubchem ID	446155
	CAS Number	93957-54-1
	CHEBI ID	38565
	TTD ID	D08GHB
	VARIDT ID	DR00124

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects BM003 Complex formation BM009 Altered absorption (Unspecific) BM010 Transporter inhibition BM011 Transporter induction BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM055 Increased risk of hepatotoxicity BM074 Increased risk of peripheral neuropathy BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Fluvastatin
Affected gastrointestinal absorption
	Complex formation					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0382		Colestipol	C11H28ClN5O	62816	Moderate		Inter Info	[42]
D0329		Cholestyramine	C27H47ClN2	137699107	Moderate		Inter Info	[42]
	Altered absorption (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1233		Pectin	C6H10O7	441476	Moderate		Inter Info	[79]
Affected cellular transport
	Transporter inhibition					Drug Num: 14
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0739		Grazoprevir	C38H50N6O9S	44603531	Major		Inter Info	[11], [12], [13]
D0155		Bempedoic acid	C19H36O5	10472693	Moderate		Inter Info	[67], [68]
D0375		Cobicistat	C40H53N7O5S2	25151504	Moderate		Inter Info	[11], [12], [73], [74], [75], [76]
D0408		Daclatasvir	C40H50N8O6	25154714	Moderate		Inter Info	[12], [78], [79]
D0425		Darolutamide	C19H19ClN6O2	67171867	Moderate		Inter Info	[12], [80]
D0561		Eltrombopag	C25H22N4O4	135449332	Moderate		Inter Info	[82], [11], [83]
D0568		Enasidenib	C19H17F6N7O	89683805	Moderate		Inter Info	[11], [84]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[11], [12], [85]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[88]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[89]
D0726		Glecaprevir	C38H46F4N6O9S	66828839	Moderate		Inter Info	[90]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[96]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[12]
D1710		Voxilaprevir	C40H52F4N6O9S	89921642	Moderate		Inter Info	[115]
	Transporter induction					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[12], [65]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 27
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[4], [5]
D0194		Bosentan	C27H29N5O6S	104865	Moderate		Inter Info	[40]
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[43], [11], [12], [44], [45], [46], [47], [48], [49], [50], [51], [4]
D0439		Delavirdine	C22H28N6O3S	5625	Moderate		Inter Info	[4], [55]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[62], [4]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[63]
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[11], [12], [62], [4]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Moderate		Inter Info	[12], [72]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[11], [12], [62], [4]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[11], [12], [62], [4]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[11], [12], [92]
D0899		Lefamulin	C28H45NO5S	25185057	Moderate		Inter Info	[93], [94], [95]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[11], [12], [62], [4]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[11], [12], [62], [4]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Moderate		Inter Info	[11], [12]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[11], [12], [62], [4]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[116], [4], [117]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[11], [12], [62], [4]
D1063		Mifepristone	C29H35NO2	55245	Moderate		Inter Info	[11], [12], [62], [4]
D1112		Nateglinide	C19H27NO3	5311309	Moderate		Inter Info	[11], [12], [62], [4]
D1143		Nitisinone	C14H10F3NO5	115355	Moderate		Inter Info	[11], [12], [62], [4]
D1195		Oxandrolone	C19H30O3	5878	Moderate		Inter Info	[11], [12], [62], [4]
D1611		Torasemide	C16H20N4O3S	41781	Moderate		Inter Info	[12], [62], [4]
D1612		Toremifene	C26H28ClNO	3005573	Moderate		Inter Info	[11], [12], [62], [4]
D1674		Valdecoxib	C16H14N2O3S	119607	Moderate		Inter Info	[124]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[11], [12], [125]
D0364		Clopidogrel	C16H16ClNO2S	60606	Minor		Inter Info	[127]
	CYP450 enzyme induction					Drug Num: 13
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[25]
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[64]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[11], [12], [77]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[11], [81]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[86], [11], [12], [87]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Moderate		Inter Info	[25]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[11], [12], [97]
D0958		Lumacaftor	C24H18F2N2O5	16678941	Moderate		Inter Info	[98], [12], [99]
D1401		Rifapentine	C47H64N4O12	135403821	Moderate		Inter Info	[108], [109]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[11], [12], [110]
D1495		Somatrem	C43H72N14O14	5487805	Moderate		Inter Info	[11], [12], [111], [110]
D1400		Rifampicin	C43H58N4O12	135398735	Moderate		Inter Info	[120], [4], [117]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[11], [12], [110]
Pharmacodynamic additive effects
	Increased risk of hepatotoxicity					Drug Num: 26
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[14], [15], [16]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[17]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[18]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[19]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[14], [15], [16]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[26], [27], [28], [11], [12], [29], [30], [31], [32], [33], [34], [35], [36]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[41]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[56], [57]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[11], [12], [58]
D0617		Ethanol	C2H6O	702	Moderate		Inter Info	[59], [60], [61]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[26], [27], [28], [11], [12], [29], [30], [31], [32], [33], [34], [35], [36]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[66]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[69], [70]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[26], [27], [28], [11], [12], [29], [30], [31], [32], [33], [34], [35], [36]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[12], [71]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[91]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[11], [100], [79]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[101], [102], [103], [104]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[11], [12], [105], [106], [107]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[12], [114]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[101], [102], [103], [104]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[101], [102], [103], [104]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[12], [118]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[119]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[26], [27], [28], [11], [12], [29], [30], [31], [32], [33], [34], [35], [36]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[122], [123]
	Increased risk of peripheral neuropathy					Drug Num: 72
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[22], [23], [24]
D0126		Auranofin	C20H34AuO9PS	24199313	Moderate		Inter Info	[22], [23], [24]
D0193		Bortezomib	C19H25BN4O4	387447	Moderate		Inter Info	[37], [38], [39]
D0260		Carboplatin	C6H12N2O4Pt	426756	Moderate		Inter Info	[22], [23], [24]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[22], [23], [24]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[22], [23], [24]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[22], [23], [24]
D0344		Cisplatin	Cl2H6N2Pt	5702198	Moderate		Inter Info	[22], [23], [24]
D0419		Dapsone	C12H12N2O2S	2955	Moderate		Inter Info	[22], [23], [24]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[22], [23], [24]
D0509		Disulfiram	C10H20N2S4	3117	Moderate		Inter Info	[22], [23], [24]
D0614		Etanercept	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0616		Ethambutol	C10H24N2O2	14052	Moderate		Inter Info	[22], [23], [24]
D1731		Ethionamide	C8H10N2S	2761171	Moderate		Inter Info	[22], [23], [24]
D0627		Etoposide	C29H32O13	36462	Moderate		Inter Info	[22], [23], [24]
D0669		Fludarabine	C10H12FN5O4	657237	Moderate		Inter Info	[22], [23], [24]
D0162		Benznidazole	C12H12N4O3	31593	Moderate		Inter Info	[22], [23], [24]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[22], [23], [24]
D0261		Carfilzomib	C40H57N5O7	11556711	Moderate		Inter Info	[22], [23], [24]
D0304		Certolizumab pegol	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[22], [23], [24]
D0496		Diiodohydroxyquinoline	C9H5I2NO	3728	Moderate		Inter Info	[22], [23], [24]
D0501		Dinutuximab	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[22], [23], [24]
D0560		Elotuzumab	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0571		Enfortumab vedotin	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[22], [23], [24]
D0736		Golimumab	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0770		Hydralazine	C8H8N4	3637	Moderate		Inter Info	[22], [23], [24]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[22], [23], [24]
D0841		Ipilimumab	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[22], [23], [24]
D0874		Ixazomib	C14H19BCl2N2O4	25183872	Moderate		Inter Info	[22], [23], [24]
D0918		Levodopa	C9H11NO4	6047	Moderate		Inter Info	[22], [23], [24]
D1113		Naxitamab	NA	NA	Moderate		Inter Info	[22], [23], [24]
D1118		Nelarabine	C11H15N5O5	3011155	Moderate		Inter Info	[22], [23], [24]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[22], [23], [24]
D1301		Pitavastatin	C25H24FNO4	5282452	Moderate		Inter Info	[22], [23], [24]
D1306		Polatuzumab vedotin	NA	NA	Moderate		Inter Info	[22], [23], [24]
D1312		Pomalidomide	C13H11N3O4	134780	Moderate		Inter Info	[22], [23], [24]
D1313		Ponatinib	C29H27F3N6O	24826799	Moderate		Inter Info	[22], [23], [24]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Moderate		Inter Info	[22], [23], [24]
D1452		Secnidazole	C7H11N3O3	71815	Moderate		Inter Info	[22], [23], [24]
D1479		Sodium aurothiomalate	C4H3AuNa2O4S	22318	Moderate		Inter Info	[22], [23], [24]
D1599		Tocilizumab	NA	NA	Moderate		Inter Info	[22], [23], [24]
D1623		Trastuzumab emtansine	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0802		Infliximab	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0821		Interferon alfa-2a, Recombinant	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0822		Interferon alfa-2b	C16H17Cl3I2N3NaO5S	71306834	Moderate		Inter Info	[22], [23], [24]
D0824		Interferon alfa-n1	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0823		Interferon alfacon-1	NA	NA	Moderate		Inter Info	[22], [23], [24]
D0858		Isoniazid	C6H7N3O	3767	Moderate		Inter Info	[22], [23], [24]
D0933		Linezolid	C16H20FN3O4	441401	Moderate		Inter Info	[22], [23], [24]
D0956		Lovastatin	C24H36O5	53232	Moderate		Inter Info	[22], [23], [24]
D1051		Metronidazole	C6H9N3O3	4173	Moderate		Inter Info	[22], [23], [24]
D1145		Nitrofurantoin	C8H6N4O5	6604200	Moderate		Inter Info	[22], [23], [24]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[22], [23], [24]
D1237		Peginterferon alfa-2a	NA	NA	Moderate		Inter Info	[22], [23], [24]
D1238		Peginterferon alfa-2b	NA	NA	Moderate		Inter Info	[22], [23], [24]
D1329		Pravastatin	C23H36O7	54687	Moderate		Inter Info	[22], [23], [24]
D1473		Simvastatin	C25H38O5	54454	Moderate		Inter Info	[22], [23], [24]
D1504		Stavudine	C10H12N2O4	18283	Moderate		Inter Info	[22], [23], [24]
D1551		Teniposide	C32H32O13S	452548	Moderate		Inter Info	[22], [23], [24]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[37], [11], [12], [121]
D1587		Tinidazole	C8H13N3O4S	5479	Moderate		Inter Info	[22], [23], [24]
D1697		Vinblastine	C46H58N4O9	13342	Moderate		Inter Info	[22], [23], [24]
D1698		Vincristine	C46H56N4O10	5978	Moderate		Inter Info	[22], [23], [24]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Moderate		Inter Info	[22], [23], [24]
D1700		Vinorelbine	C45H54N4O8	5311497	Moderate		Inter Info	[22], [23], [24]
D1714		Zafirlukast	C31H33N3O6S	5717	Moderate		Inter Info	[22], [23], [24]
D1715		Zalcitabine	C9H13N3O3	24066	Moderate		Inter Info	[37], [126]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 9
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0360		Clofibrate	C12H15ClO3	2796	Major		Inter Info	[1], [2], [3]
D0642		Fenofibrate	C20H21ClO4	3339	Major		Inter Info	[1], [2], [3]
D0380		Colchicine	C22H25NO6	6167	Major		Inter Info	[6], [7], [8]
D0643		Fenofibric acid	C17H15ClO4	64929	Major		Inter Info	[9], [10]
D0715		Gemfibrozil	C15H22O3	3463	Major		Inter Info	[1], [2], [3]
D0902		Lenalidomide	C13H13N3O3	216326	Major		Inter Info	[12], [20], [21]
D0421		Daptomycin	C72H101N17O26	16134395	Moderate		Inter Info	[52], [53], [54]
D1543		Telbivudine	C10H14N2O5	159269	Moderate		Inter Info	[112], [113]
D1720		Zidovudine	C10H13N5O4	35370	Moderate		Inter Info	[112], [113]

References
1	Backman JT, Kyrklund C, Neuvonen M, Neuvonen PJ "Gemfibrozil greatly increases plasma concentrations of cerivastatin." Clin Pharmacol Ther 72 (2002): 685-91.[PMID: 12496749]
2	Duell PB, Connor WE, Illingworth DR "Rhabdomyolysis after taking atorvastatin with gemfibrozil." Am J Cardiol 81 (1998): 368-9.[PMID: 9468088]
3	Mastroianni CM, dEttorre G, Forcina G, Lichtner M, Corpolongo A, Coletta S, Vullo V "Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia." AIDS 15 (2001): 820-1.[PMID: 11371708]
4	Product Information. Lescol (fluvastatin). Novartis Pharmaceuticals, East Hanover, NJ.
5	Spach DH, Bauwens JE, Clark CD, Burke WG "Rhabdomyolysis associated with lovastatin and erythromycin use." West J Med 154 (1991): 213-5. [PMID: 2006579]
6	Colchicine: serious interactions. Prescrire Int 17 (2008): 151-3. [PMID: 19492485]
7	Wilbur K, Makowsky M "Colchicine myotoxicity: case reports and literature review." Pharmacotherapy 24 (2004): 1784-92. [PMID: 15585444]
8	Montiel V, Huberlant V, Vincent MF, Bonbled F, Hantson P "Multiple organ failure after an overdose of less than 0.4 mg/kg of colchicine: role of coingestants and drugs during intensive care management." Clin Toxicol (Phila) 48 (2010): 845-8.[PMID: 20969505]
9	Product Information. Trilipix (fenofibric acid). Abbott Pharmaceutical, Abbott Park, IL.
10	Unal A, Torun E, Sipahioglu MH, et al. "Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients." Intern Med 47 (2008): 1017-9.[PMID: 18520113]
11	Cerner Multum, Inc. "Australian Product Information.".
12	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
13	Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
14	Canadian Pharmacists Association.
15	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
16	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
17	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
18	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
19	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
20	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
21	EMA. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP) "Revlimid."
22	Carrion C, Espinosa E, Herrero A, Garcia B "Possible vincristine-isoniazid interaction." Ann Pharmacother 29 (1995): 201. [PMID: 7756727]
23	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
24	Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online."
25	Product Information. Emend (aprepitant). Merck & Company Inc, West Point, PA.
26	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
27	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
28	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
29	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
30	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
31	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
32	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
33	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
34	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
35	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
36	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
37	Argov Z, Mastaglia FL "Drug-induced peripheral neuropathies." Br Med J 1 (1979): 663-6. [PMID: 219931]
38	Cavaletti G, Jakubowiak AJ "Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies." Leuk Lymphoma 51 (2010): 1178-87. [PMID: 20497001]
39	Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
40	Product Information. Tracleer (bosentan). Acetelion Pharmaceuticals US, Inc, South San Francisco, CA.
41	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
42	Smith HT, Jokubaitis LA, Troendle AJ, Hwang DS, Robinson WT "Pharmacokinetics of fluvastatin and specific drug interactions." Am J Hypertens 6 (1993): s375-82. [PMID: 8297546]
43	Austen JL, Shifrin FA, Bartucci MR, Knauss TC, Schulak JA, Hricik DE "Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy." Ann Pharmacother 30 (1996): 1386-9. [PMID: 8968448]
44	Corpier CL, Jones PH, Suki WN, et al. "Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients." JAMA 260 (1988): 239-41. [PMID: 3290520]
45	East C, Alivizatos PA, Grundy SM, Jones PH, Farmer JA "Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation." N Engl J Med 318 (1988): 47-8. [PMID: 3275892]
46	Jardine A, Holdaas H "Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience." J Clin Pharm Ther 24 (1999): 397-408. [PMID: 10651972]
47	Li PKT, Mak TWL, Chan TH, Wang A, Lam CWK, Lai KN "Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteineimia." Transplantation 60 (1995): 652-6. [PMID: 7570971]
48	Li PKT, Mak TWL, Wang AYM, Lee YT, Leung CB, Lui SF, Lam CWK, Lai KN "The interaction of fluvastatin and cyclosporin a in renal transplant patients." Int J Clin Pharmacol Ther 33 (1995): 246-8. [PMID: 7620696]
49	Locsey L, Asztalos L, Kincses Z, Balazs G "Fluvastatin (Lescol) treatment of hyperlipidaemia in patients with renal transplants." Int Urol Nephrol 29 (1997): 95-106. [PMID: 9203045]
50	Malyszko JS, Malyszko J, Mysliwiec M "Serum lipids and hemostasis in kidney allograft recipients treated with fluvastatin (Lescol) for 3 months." Transplant Proc 32 (2000): 1344-6. [PMID: 10995974]
51	Norman DJ, Illingworth DR, Munson J, Hosenpud J "Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin." N Engl J Med 318 (1988): 46-7. [PMID: 3275891]
52	Product Information. Vytorin (ezetimibe-simvastatin). Merck &amp Company Inc, West Point, PA.
53	Product Information. Zocor (simvastatin). Merck &amp Co, Inc, West Point, PA.
54	Product Information. Cubicin (daptomycin). Cubist Pharmaceuticals Inc, Lexington, MA.
55	Product Information. Rescriptor (delavirdine). Pharmacia and Upjohn, Kalamazoo, MI.
56	Elsharkawy AM, Schwab U, McCarron B, et al. "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser." J Clin Virol 58 (2013): 331-3. [PMID: 23763943]
57	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
58	Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
59	Product Information. Crestor (rosuvastatin). AstraZeneca Pharma Inc, Mississauga, ON.
60	Product Information. Lipitor (atorvastatin). Parke-Davis, Morris Plains, NJ.
61	Product Information. Pravachol (pravastatin). Bristol-Myers Squibb, Princeton, NJ.
62	Kantola T, Backman JT, Niemi M, Kivisto KT, Neuvonen PJ "Effect of fluconazole on plasma fluvastatin and pravastatin concentrations." Eur J Clin Pharmacol 56 (2000): 225-9. [PMID: 10952477]
63	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
64	Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
65	Product Information. Erleada (apalutamide). Janssen Biotech, Inc., Horsham, PA, PA.
66	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
67	Product Information. Nexletol (bempedoic acid). Esperion Therapeutics, Ann Arbor, MI.
68	Product Information. Nexlizet (bempedoic acid-ezetimibe). Esperion Therapeutics, Ann Arbor, MI.
69	Product Information. Accolate (zafirlukast). Zeneca Pharmaceuticals, Wilmington, DE.
70	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
71	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
72	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
73	Product Information. Evotaz (atazanavir-cobicistat). Bristol-Myers Squibb, Princeton, NJ.
74	Product Information. Prezcobix (cobicistat-darunavir). Janssen Pharmaceuticals, Titusville, NJ.
75	Product Information. Symtuza (cobicistat/darunavir/emtricitabine/tenof). Janssen Pharmaceuticals, Titusville, NJ.
76	Suttels V, Florence E, Leys J, et al. "A 68-year old male presenting with rhabdomyolysis-associated acute kidney injury following concomitant use of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate and pravastatin/fenofibrate: a case report." J Med Case Reports 9 (2015): 190. [PMID: 26347243]
77	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
78	Product Information. Daklinza (daclatasvir). Bristol-Myers Squibb, Princeton, NJ.
79	Richter WO, Jacob BG, Schwandt P "Interaction between fibre and lovastatin." Lancet 338 (1991): 706. [PMID: 1679514]
80	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
81	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
82	Allred AJ, Bowen CJ, Park JW, et al. "Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers." Br J Clin Pharmacol 72 (2011): 321-9. [PMID: 21434975]
83	Canadian Pharmacists Association "e-CPS."
84	Product Information. Idhifa (enasidenib). Celgene Corporation, Summit, NJ.
85	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
86	Benoist G, van Oort I, et al "Drug-drug interaction potential in men treated with enzalutamide: Mind the gap." Br J Clin Pharmacol 0 (2017): epub. [PMID: 28881501]
87	Product Information. Xtandi (enzalutamide). Astellas Pharma US, Inc, Deerfield, IL.
88	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
89	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
90	Product Information. Mavyret (glecaprevir-pibrentasvir). Abbott Pharmaceutical, Abbott Park, IL.
91	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
92	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
93	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
94	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
95	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
96	Product Information. Prevymis (letermovir). Merck & Company Inc, Whitehouse Station, NJ.
97	Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
98	Cerner Multum, Inc. "Canadian Product Information.".
99	Product Information. Orkambi (ivacaftor-lumacaftor). Vertex Pharmaceuticals, Cambridge, MA.
100	Product Information. Votrient (pazopanib). GlaxoSmithKline, Research Triangle Park, NC.
101	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
102	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
103	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
104	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
105	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
106	Gilead Sciences, Inc "About Remdesivir.".
107	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
108	Product Information. Priftin (rifapentine). Hoechst Marion-Roussel Inc, Kansas City, MO.
109	Thijssen HH, Flin ois JP, Beaune PH "Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes." Drug Metab Dispos 28 (2000): 1284-90. [PMID: 11038154]
110	Product Information. Zorbtive (somatropin). Serono Laboratories Inc, Rockland, MA.
111	Product Information. Humatrope (somatropin). Lilly, Eli and Company, Indianapolis, IN.
112	Product Information. Retrovir (zidovudine). Glaxo Wellcome, Research Triangle Park, NC.
113	Product Information. Tyzeka (telbivudine). IDEC Pharmaceuticals Corporation, San Diego, CA.
114	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
115	Product Information. Vosevi (sofosbuvir/velpatasvir/voxilaprevir). Gilead Sciences, Foster City, CA.
116	Appel S, Rufenacht T, Kalafsky G, et al. "Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus." Am J Cardiol 76 (1995): a29-32. [PMID: 7604792]
117	Scripture CD, Pieper JA "Clinical pharmacokinetics of fluvastatin." Clin Pharmacokinet 40 (2001): 263-81. [PMID: 11368292]
118	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
119	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
120	Everett DW, Chando TJ, Didonato GC, Singhvi SM, Pan HY, Weinstein SH "Biotransformation of pravastatin sodium in humans." Drug Metab Dispos 19 (1991): 740-8. [PMID: 1680649]
121	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
122	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
123	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
124	Product Information. Bextra (valdecoxib). Pharmacia Corporation, Peapack, NJ.
125	Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
126	Product Information. Hivid (zalcitabine). Roche Laboratories, Nutley, NJ.
127	Product Information. Plavix (clopidogrel). Bristol-Myers Squibb, Princeton, NJ.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence